Sagittarius Life Science Corp (TPEX:3205)
50.50
+2.50 (5.21%)
At close: Feb 11, 2026
Sagittarius Life Science Revenue
Sagittarius Life Science had revenue of 92.88M TWD in the quarter ending September 30, 2025, a decrease of -18.86%. This brings the company's revenue in the last twelve months to 424.44M, down -6.79% year-over-year. In the year 2024, Sagittarius Life Science had annual revenue of 467.75M with 6.20% growth.
Revenue (ttm)
424.44M
Revenue Growth
-6.79%
P/S Ratio
8.04
Revenue / Employee
3.79M
Employees
112
Market Cap
3.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 467.75M | 27.29M | 6.20% |
| Dec 31, 2023 | 440.46M | -88.61M | -16.75% |
| Dec 31, 2022 | 529.07M | -58.55M | -9.96% |
| Dec 31, 2021 | 587.61M | 29.43M | 5.27% |
| Dec 31, 2020 | 558.19M | 119.47M | 27.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.13B |
| Apex Biotechnology | 1.96B |
| SYN-TECH Chem. & Pharm. | 1.29B |
| Genovate Biotechnology | 491.23M |
| 3D Global Biotech | 324.87M |
| G&E Herbal Biotechnology | 311.78M |
| HeXun Biosciences | 290.83M |
| Intech Biopharm | 113.85M |